MAPK3 and visceral leishmaniasis: These results suggest that arsenic exposure may induce an increase in ERK-1/2 expression while concurrently suppressing the p38-MAPK signaling cascade, resulting in an aggravation of visceral leishmaniasis (VL) in individuals subjected to continuous arsenic exposure.